The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in certain cases, officials said.
Senators continued talks over resolving the government shutdown, with Republicans saying they are waiting to hear from Democrats. Follow live updates here.
